About West Milwaukee Comprehensive Treatment Center
West Milwaukee Comprehensive Treatment Center is an outpatient opioid addiction treatment center in West Milwaukee, Wisconsin, specializing in medication assisted treatment for adults struggling with opioid use disorder. The clinic offers FDA-approved medications combined with individual and group counseling to support lasting recovery. The center provides individualized treatment planning through comprehensive intake assessments, ongoing monitoring and a focus on relapse prevention and coping skills.
Medication Assisted Treatment at West Milwaukee Comprehensive
Treatment begins with an intake assessment and individualized plan that pairs medication with counseling. Unlike traditional methadone-only clinics, West Milwaukee Comprehensive Treatment Center offers multiple MAT medication options, including methadone maintenance, buprenorphine maintenance, Suboxone maintenance and Vivitrol maintenance, allowing the care team to tailor medication to each person's needs and history.
Clients participate in both individual counseling and group therapy sessions designed to address the behavioral and emotional aspects of opioid addiction. The program emphasizes active participation, relapse prevention strategies and recovery planning, with take home dosing available for eligible clients to support flexibility and independence as they progress.
Quick Facts:West Milwaukee Comprehensive Treatment Center
- Location: 1610 Miller Parkway, West Milwaukee, Wisconsin, with convenient access to the greater Milwaukee area
- Level of care: Outpatient medication assisted treatment (MAT) for opioid use disorder
- Who they treat: Adults ages 18 and older of all genders, including those with chronic relapse
- Approach: Individualized treatment planning with ongoing medication monitoring and counseling support
- Payment options: Accepts most insurance, including Medicaid, Medicare, commercial plans, Tricare, Veterans Affairs and self-pay
- Special features: Same-day admission, 24/7 appointment scheduling and take-home dosing availability
